{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T01:20:46Z","timestamp":1769908846710,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00277-024-05724-w","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:04:24Z","timestamp":1711584264000},"page":"1729-1736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of rabbit ATLG and ATG for GVHD prophylaxis in hematological malignancies with haploidentical hematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"103","author":[{"given":"Zhengqin","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qihang","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hexian","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongmu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"issue":"3 Suppl","key":"5724_CR1","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.bbmt.2016.01.006","volume":"22","author":"J Apperley","year":"2016","unstructured":"Apperley J, Niederwieser D, Huang XJ et al (2016) Reprint of: Haploidentical hematopoietic stem cell transplantation: A global overview comparing Asia, the European Union, and the United States. Biol Blood Marrow Transpl 22(3 Suppl):S15\u2013S18","journal-title":"Biol Blood Marrow Transpl"},{"issue":"12","key":"5724_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H Dohner","year":"2022","unstructured":"Dohner H, Wei AH, Appelbaum FR et al (2022) Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140(12):1345\u20131377","journal-title":"Blood"},{"issue":"5","key":"5724_CR3","first-page":"e4614","volume":"11","author":"NR Shah","year":"2019","unstructured":"Shah NR, Leone A, Rothbaum R et al (2019) Cutaneous chronic graft versus host disease in a symmetric distribution. Cureus 11(5):e4614","journal-title":"Cureus"},{"issue":"1","key":"5724_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41467-020-20240-x","volume":"12","author":"F Zhang","year":"2021","unstructured":"Zhang F, Zuo T, Yeoh YK et al (2021) Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease. Nat Commun 12(1):65","journal-title":"Nat Commun"},{"issue":"29","key":"5724_CR5","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1200\/JCO.20.00150","volume":"38","author":"YJ Chang","year":"2020","unstructured":"Chang YJ, Wu DP, Lai YR et al (2020) Antithymocyte Globulin for Matched Sibling Donor transplantation in patients with hematologic malignancies: a Multicenter, Open-Label, Randomized Controlled Study. J Clin Oncol 38(29):3367\u20133376","journal-title":"J Clin Oncol"},{"issue":"7","key":"5724_CR6","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41409-018-0393-0","volume":"54","author":"A Kumar","year":"2019","unstructured":"Kumar A, Reljic T, Hamadani M et al (2019) Antithymocyte globulin for graft-versus-host disease prophylaxis: an updated systematic review and meta-analysis. Bone Marrow Transpl 54(7):1094\u20131106","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"5724_CR7","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1016\/S2352-3026(19)30220-0","volume":"7","author":"I Walker","year":"2020","unstructured":"Walker I, Panzarella T, Couban S et al (2020) Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial. Lancet Haematol 7(2):e100\u2013e111","journal-title":"Lancet Haematol"},{"issue":"7","key":"5724_CR8","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","volume":"21","author":"M Mohty","year":"2007","unstructured":"Mohty M (2007) Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 21(7):1387\u20131394","journal-title":"Leukemia"},{"issue":"12","key":"5724_CR9","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1111\/ajt.12514","volume":"13","author":"I Popow","year":"2013","unstructured":"Popow I, Leitner J, Grabmeier-Pfistershammer K et al (2013) A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations. Am J Transpl 13(12):3103\u20133113","journal-title":"Am J Transpl"},{"issue":"1","key":"5724_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/TP.0b013e31823bb664","volume":"93","author":"I Popow","year":"2012","unstructured":"Popow I, Leitner J, Majdic O et al (2012) Assessment of batch to batch variation in polyclonal antithymocyte globulin preparations. Transplantation 93(1):32\u201340","journal-title":"Transplantation"},{"issue":"1","key":"5724_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11684-017-0595-7","volume":"13","author":"M Lv","year":"2019","unstructured":"Lv M, Chang Y, Huang X (2019) Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation. Front Med 13(1):45\u201356","journal-title":"Front Med"},{"issue":"2","key":"5724_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3324\/haematol.2016.148510","volume":"102","author":"F Baron","year":"2017","unstructured":"Baron F, Mohty M, Blaise D et al (2017) Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and marrow transplantation. Haematologica 102(2):224\u2013234","journal-title":"Haematologica"},{"issue":"3","key":"5724_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.transproceed.2004.02.053","volume":"36","author":"LS De Santo","year":"2004","unstructured":"De Santo LS, Della Corte A, Romano G et al (2004) Midterm results of a prospective randomized comparison of two different rabbit-antithymocyte globulin induction therapies after heart transplantation. Transpl Proc 36(3):631\u2013637","journal-title":"Transpl Proc"},{"issue":"7","key":"5724_CR14","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/01.TP.0000116442.81259.60","volume":"77","author":"D Ducloux","year":"2004","unstructured":"Ducloux D, Kazory A, Challier B et al (2004) Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study. Transplantation 77(7):1029\u20131033","journal-title":"Transplantation"},{"key":"5724_CR15","doi-asserted-by":"crossref","unstructured":"Jordan J, Goldstein JS, Jaye DL, Gurcan M, Flowers CR, Cooper LAD (2018) Informatics approaches to address New challenges in the classification of lymphoid malignancies. JCO Clin Cancer Inf, ;2:CCI.17.00039.","DOI":"10.1200\/CCI.17.00039"},{"issue":"13","key":"5724_CR16","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.3390\/cancers13133170","volume":"13","author":"P Bernasconi","year":"2021","unstructured":"Bernasconi P, Borsani O (2021) Eradication of measurable residual disease in AML: a challenging clinical goal. Cancers (Basel) 13(13):3170","journal-title":"Cancers (Basel)"},{"issue":"24","key":"5724_CR17","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","volume":"21","author":"BD Cheson","year":"2003","unstructured":"Cheson BD, Bennett JM, Kopecky KJ et al (2003) Revised recommendations of the International Working Group for Diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in Acute myeloid leukemia. J Clin Oncol 21(24):4642\u20134649","journal-title":"J Clin Oncol"},{"issue":"4","key":"5724_CR18","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H Dohner","year":"2017","unstructured":"Dohner H, Estey E, Grimwade D et al (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129(4):424\u2013447","journal-title":"Blood"},{"issue":"4","key":"5724_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner C et al (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18(4):295\u2013304","journal-title":"Transplantation"},{"issue":"1","key":"5724_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00277-023-05502-0","volume":"103","author":"X Fei","year":"2024","unstructured":"Fei X, Zhang W, Gu Y et al (2024) CLAG combined with total body irradiation as intensive conditioning chemotherapy prior to allogeneic hematopoietic stem cell transplantation in patients with refractory or relapsed acute myeloid leukemia. Ann Hematol 103(1):241\u2013249","journal-title":"Ann Hematol"},{"key":"5724_CR21","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/sim.7501","volume":"36","author":"PC Austin","year":"2017","unstructured":"Austin PC, Fine JP (2017) Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med 36:4391\u20134400","journal-title":"Stat Med"},{"issue":"10","key":"5724_CR22","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/sj.bmt.1704957","volume":"35","author":"N Basara","year":"2005","unstructured":"Basara N, Baurmann H, Kolbe K et al (2005) Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group. Bone Marrow Transpl 35(10):1011\u20131018","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"5724_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3109\/10428194.2015.1045901","volume":"57","author":"W Huang","year":"2016","unstructured":"Huang W, Yu L, Cao T et al (2016) The efficacy and safety of rabbit anti-thymocyte globulin vs rabbit anti-T-lymphocyte globulin in peripheral blood stem cell transplantation from unrelated donors. Leuk Lymphoma 57(2):355\u2013363","journal-title":"Leuk Lymphoma"},{"key":"5724_CR24","doi-asserted-by":"publisher","first-page":"980924","DOI":"10.1155\/2015\/980924","volume":"2015","author":"S Paiano","year":"2015","unstructured":"Paiano S, Roosnek E, Tirefort Y et al (2015) Comparing two types of rabbit ATG prior to reduced intensity conditioning allogeneic hematopoietic SCT for hematologic malignancies. Bone Marrow Res 2015:980924","journal-title":"Bone Marrow Res"},{"issue":"11","key":"5724_CR25","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1080\/10428194.2018.1439584","volume":"59","author":"N Polverelli","year":"2018","unstructured":"Polverelli N, Malagola M, Turra A et al (2018) Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years. Leuk Lymphoma 59(11):2700\u20132705","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"5724_CR26","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/sj.bmt.1701991","volume":"24","author":"M Remberger","year":"1999","unstructured":"Remberger M, Svahn BM, Hentschke P et al (1999) Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation. Bone Marrow Transpl 24(8):823\u2013830","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"5724_CR27","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00277-023-05220-7","volume":"102","author":"L Wang","year":"2023","unstructured":"Wang L, Kong P, Zhang C et al (2023) Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme. Ann Hematol 102(6):1569\u20131579","journal-title":"Ann Hematol"},{"issue":"6","key":"5724_CR28","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s00277-020-04014-5","volume":"99","author":"L Zhou","year":"2020","unstructured":"Zhou L, Gao ZY, Lu DP (2020) Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical hematopoietic stem cell transplantation: a single-center experience. Ann Hematol 99(6):1389\u20131400","journal-title":"Ann Hematol"},{"issue":"3","key":"5724_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.hemonc.2018.01.004","volume":"11","author":"C Boga","year":"2018","unstructured":"Boga C, Yeral M, Gereklioglu C et al (2018) Effects of two doses of anti-T lymphocyte globulin-Fresenius given after full-match sibling stem cell transplantation in acute myeloblastic leukemia patients who underwent myeloablative fludarabine\/busulfan conditioning. Hematol Oncol Stem Cell Ther 11(3):149\u2013157","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"10","key":"5724_CR30","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/bmt.2015.148","volume":"50","author":"L Binkert","year":"2015","unstructured":"Binkert L, Medinger M, Halter JP et al (2015) Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation. Bone Marrow Transpl 50(10):1331\u20131336","journal-title":"Bone Marrow Transpl"},{"key":"5724_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fimmu.2019.00315","volume":"10","author":"LVE Oostenbrink","year":"2019","unstructured":"Oostenbrink LVE, Jol-van der Zijde CM, Kielsen K et al (2019) Differential Elimination of Anti-thymocyte Globulin of Fresenius and Genzyme impacts T-Cell reconstitution after hematopoietic stem cell transplantation. Front Immunol 10:315","journal-title":"Front Immunol"},{"issue":"5","key":"5724_CR32","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1016\/S2352-3026(15)00045-9","volume":"2","author":"R Admiraal","year":"2015","unstructured":"Admiraal R, van Kesteren C, Jol-van der Zijde CM et al (2015) Association between anti-thymocyte globulin exposure and CD4\u2009+\u2009immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis. Lancet Haematol 2(5):e194\u2013203","journal-title":"Lancet Haematol"},{"issue":"11","key":"5724_CR33","doi-asserted-by":"publisher","first-page":"e0165233","DOI":"10.1371\/journal.pone.0165233","volume":"11","author":"F Burkhalter","year":"2016","unstructured":"Burkhalter F, Schaub S, Bucher C et al (2016) A comparison of two types of rabbit antithymocyte globulin induction therapy in immunological high-risk kidney recipients: a prospective Randomized Control Study. PLoS ONE 11(11):e0165233","journal-title":"PLoS ONE"},{"issue":"2","key":"5724_CR34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s12032-014-0465-y","volume":"32","author":"W Huang","year":"2015","unstructured":"Huang W, Zhao X, Tian Y et al (2015) Outcomes of peripheral blood stem cell transplantation patients from HLA-mismatched unrelated donor with antithymocyte globulin (ATG)-Thymoglobulin versus ATG-Fresenius: a single-center study. Med Oncol 32(2):465","journal-title":"Med Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05724-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05724-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05724-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T06:05:28Z","timestamp":1712901928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05724-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["5724"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05724-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,28]]},"assertion":[{"value":"26 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of Aerospace Center Hospital, Beijing, China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement"}},{"value":"Written informed consent was obtained from the adult patients and the guardians of children patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient approval statement"}},{"value":"The authors have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}